Pancragen is a synthetic tetrapeptide bioregulator (sequence: Lys-Glu-Asp-Trp or KEDW) designed to target the tissues of the pancreas. Developed largely within the framework of Vladimir Khavinson’s research on “peptide bioregulators,” it is theorized to work at the epigenetic level to support pancreatic function.

Core Benefits (Theorized)
Most reported benefits come from preclinical models and Russian gerontology studies. It is primarily marketed for its potential to:

• Support Insulin Production: Research suggests it may help normalize the function of beta cells in the Islets of Langerhans, potentially stabilizing blood sugar levels.
• Improve Digestive Function: By targeting exocrine cells, it is believed to help the pancreas produce digestive enzymes more efficiently.
• Anti-Aging & Cellular Repair: It is claimed to stimulate protein synthesis and cellular regeneration within the pancreas, potentially slowing the “aging” of the organ.
• Metabolic Syndrome Support: Some data suggests it may reduce the severity of metabolic disorders, including improving glucose tolerance and insulin sensitivity.

Clinical Data & Research Findings
The majority of data on Pancragen originates from the St. Petersburg Institute of Bioregulation and Gerontology.

Study Type	Key Findings
Animal (Non-human Primates)	Studies on aged rhesus monkeys reported that Pancragen normalized insulin and C-peptide levels within 10 days, with effects lasting up to three weeks.
Epigenetic Research	Findings suggest the peptide interacts directly with DNA and histones (specifically wheat histones in some lab models), potentially “unlocking” genes that promote cell differentiation and growth.
Preclinical (Rodents)	Observed improvements in microvascular parameters (blood flow) within the pancreas and a reduction in apoptosis (programmed cell death) of pancreatic cells.
Human Clinical Use	In Eastern Europe, it is sometimes used as a “parapharmaceutical.” Reported outcomes include reduced symptoms of chronic pancreatitis and better blood sugar control when used alongside standard therapies.